1st Quarter - Report

KING & SPALDING LLP for NCCR

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Biomedical research funding, including provisions in: H.R. 1, the American Recovery and Reinvestment Act and H.R. 1105, the Omnibus Appropriations Act, 2009

LobbyistCovered position, as disclosed
JASON S MCKITRICK —
MARK H SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (111th), H.R. 1105 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.